These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37010735)

  • 1. The clinical value of monoclonal protein in ANCA-associated vasculitis with renal involvement.
    Wang Y; Yang K; Yu Z; Huang Y; He T; Xiong J; Zhao J
    Int Urol Nephrol; 2023 Nov; 55(11):2925-2933. PubMed ID: 37010735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased renal damage in hypocomplementemic patients with ANCA-associated vasculitis: retrospective cohort study.
    García L; Pena CE; Maldonado RÁ; Costi C; Mamberti M; Martins E; García MA
    Clin Rheumatol; 2019 Oct; 38(10):2819-2824. PubMed ID: 31222573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
    Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
    Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical analysis of ANCA-associated renal vasculitis patients with chronic dialysis.
    Chen YX; Zhang W; Chen XN; Ni LY; Shen PY; Wang WM; Chen N
    Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S5-10. PubMed ID: 24480250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Ahn SS; Pyo JY; Song JJ; Park YB; Lee SW
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454396
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients.
    Park PG; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    BMC Nephrol; 2022 Aug; 23(1):288. PubMed ID: 35982401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the correlation of commonly used laboratory tests with clinical activity, renal involvement and treatment of systemic small-vessel vasculitis with the presence of ANCA antibodies.
    Mosakowska M; Kania DB; Szamotulska K; Rymarz A; Niemczyk S
    BMC Nephrol; 2021 Aug; 22(1):290. PubMed ID: 34445984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of platelets and complement C3 as link between innate immunity and tubulointerstitial injury in renal vasculitis with MPO-ANCA seropositivity.
    Baier E; Tampe D; Kluge IA; Hakroush S; Tampe B
    Front Immunol; 2022; 13():1054457. PubMed ID: 36439156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.
    Clerte M; Philip R; Levi C; Cornec-Le Gall E; Audard V; Huart A; Puéchal X; Touzot M; Rabot N; Thervet É; Aouba A; Karras A
    Scand J Rheumatol; 2022 May; 51(3):205-213. PubMed ID: 34169779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of complement factor C3 at diagnosis can predict outcome in antineutrophil antibody associated vasculitis.
    Scurt FG; Hirschfeld V; Ganz M; Mertens PR; Chatzikyrkou C
    J Nephrol; 2023 Nov; 36(8):2281-2293. PubMed ID: 37418090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of lung diseases predict survival in patients with MPO-ANCA-associated vasculitis: a single-center retrospective study.
    Yang S; Chai D; Li Y; Wang Y; Zhan X; Zhang L; Wang J; Ye Q
    Clin Rheumatol; 2022 Mar; 41(3):783-793. PubMed ID: 34839416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab in relapsing and de novo MPO ANCA-associated vasculitis with severe renal involvement: a case series.
    Caroti L; Cirami CL; Di Maria L; Larti A; Carta P; Dervishi E; Farsetti S; Tsalouchos A; Novelli L; Minetti EE
    BMC Nephrol; 2019 May; 20(1):162. PubMed ID: 31088509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.
    Hu X; Shen C; Meng T; Ooi JD; Eggenhuizen PJ; Zhou YO; Luo H; Chen JB; Lin W; Gong Y; Xiong Q; Xu J; Liu N; Xiao X; Tang R; Zhong Y
    Front Immunol; 2022; 13():991469. PubMed ID: 36389826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the risk factors for end‑stage renal disease and mortality in ANCA-associated vasculitis: a study from a single center of the Chinese Rheumatism Data Center.
    Guo Q; Yu L; Zhang X; Shang J; Duan X
    Clin Rheumatol; 2023 Feb; 42(2):489-499. PubMed ID: 36367596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes of patients with antineutrophil cytoplasmic antibody-positive systemic lupus erythematosus.
    Wang Y; Yu X; Xie X; Li H; Yang W; Liang Y; Lu W
    Ren Fail; 2023 Dec; 45(1):2235431. PubMed ID: 37470370
    [No Abstract]   [Full Text] [Related]  

  • 18. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathological prognostic factors affecting the renal outcomes in childhood ANCA-associated vasculitis.
    Özçelik G; Sönmez HE; Şahin S; Özağarı A; Bayram MT; Çiçek RY; Çakıcı EK; Çomak E; Barut K; Şahin N; Bakkaloğlu S; Gökçe İ; Düzova A; Bilginer Y; Açarı C; Melek E; Kılıç BD; Özdel S; Adroviç A; Kasapçopur Ö; Ünsal E; Alpay H; Orhan D; Topaloğlu R; Düşünsel R; Özen S
    Pediatr Nephrol; 2019 May; 34(5):847-854. PubMed ID: 30607566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoo BW; Song JJ; Park YB; Lee SW
    Korean J Intern Med; 2021 May; 36(3):731-741. PubMed ID: 32811130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.